Sorafenib Monotherapy Versus Sorafenib Combined with Regional Therapies for Hepatocellular Carcinoma Patients with Pulmonary Oligometastases: A Propensity Score-matched Analysis

Background: Sorafenib has been recommended as the standard therapy for advanced HCC with extrahepatic metastasis. The purpose of this retrospective study was to investigate the difference in overall survival (OS) between treatments with sorafenib combined with regional therapies versus sorafenib mon...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jinbin, Lu, Shixun, Zhang, Yaojun, Xu, Li, Chen, Jiancong, Wang, Juncheng, Chen, Minshan, Zhang, Rongxin, Zhou, Zhongguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968762/
https://www.ncbi.nlm.nih.gov/pubmed/29805700
http://dx.doi.org/10.7150/jca.24568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968762/
https://www.ncbi.nlm.nih.gov/pubmed/29805700
http://dx.doi.org/10.7150/jca.24568

Ejemplares similares